Triage Survey for Psychiatry Research Eligibility (TRIAGE-Psych)

May 18, 2026 updated by: Adams Clinical
TRIAGE-Psych is a survey study designed to assess potential participants' eligibility to screen for industry-sponsored psychiatry clinical trials.

Study Overview

Status

Recruiting

Conditions

Intervention / Treatment

Study Type

Observational

Enrollment (Estimated)

20000

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

  • United States
    • Massachusetts
      • Boston, Massachusetts, United States, 02116
        • Recruiting
        • Adams Clinical, Boston
        • Principal Investigator:
          • Dyanna Domilici, MD
        • Contact:
      • Watertown, Massachusetts, United States, 02472
        • Recruiting
        • Adams Clinical, Watertown
        • Contact:
        • Principal Investigator:
          • Miriam Evans, PhD
    • New York
      • New York, New York, United States, 10029
        • Recruiting
        • Adams Clinical, Harlem
        • Contact:
        • Principal Investigator:
          • Wesley Gregory, PHD
      • The Bronx, New York, United States, 10461
        • Recruiting
        • Adams Clinical, Bronx
        • Principal Investigator:
          • Shama Farooq, MD
        • Contact:
    • Pennsylvania
      • Philadelphia, Pennsylvania, United States, 19104
        • Recruiting
        • Adams Clinical, Philadelphia
        • Contact:
        • Principal Investigator:
          • Cassie Blanchard, PHD
    • Texas
      • DeSoto, Texas, United States, 75115
        • Recruiting
        • Adams Clinical, Dallas
        • Principal Investigator:
          • Rajinder Shiwach, MD
        • Contact:

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Sampling Method

Non-Probability Sample

Study Population

Participants of any sex, age 18+, who have expressed interest in participating in an industry-sponsored clinical trial of an investigational product for indications in psychiatry will be screened for clinical appropriateness for a study trial.

Description

Inclusion Criteria:

  • Participant or Legally Authorized Representative has signed an ICF prior to study-specific procedures being performed.
  • Participant is at least 18 years old.

Exclusion Criteria:

  • Participant is pregnant, breast-feeding, or planning to become pregnant.
  • History of a clinically significant illness which in the investigator's opinion may impact participant safety or the ability to analyze study results.
  • Participant represents an acute suicidal risk, as defined as a "yes" response to ideation on C-SSRS questions 4 or 5, or answer "yes" to behavior questions within 90 days of screening.
  • Moderate or severe substance use disorder within 90 days prior to screen, according to DSM-5 criteria that in the investigator's opinion could pose undue risk to the participant.
  • Any condition that in the investigator's opinion makes a participant unsuitable for the study.
  • Currently employed by Adams Clinical or a first-degree relative of an employee.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
The proportion of participants who are eligible for industry-sponsored clinical trials, as defined as those who go on to screen for a study
Time Frame: Up to 52 weeks
Up to 52 weeks

Secondary Outcome Measures

Outcome Measure
Time Frame
The proportion of participants who enroll in industry-sponsored clinical trials
Time Frame: Up to 52 weeks
Up to 52 weeks
The prevalence of disqualifying comorbid conditions that prevent screening or enrollment in industry-sponsored clinical trials
Time Frame: Up to 52 weeks
Up to 52 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Adams Clinical

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

December 21, 2021

Primary Completion (Estimated)

December 31, 2027

Study Completion (Estimated)

December 31, 2027

Study Registration Dates

First Submitted

March 24, 2023

First Submitted That Met QC Criteria

March 24, 2023

First Posted (Actual)

April 6, 2023

Study Record Updates

Last Update Posted (Actual)

May 20, 2026

Last Update Submitted That Met QC Criteria

May 18, 2026

Last Verified

May 1, 2026

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • TRIAGE-Psych-101

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Generalized Anxiety Disorder

Clinical Trials on Survey

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Mozambique

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Subscribe